Kratom Safety Concerns Escalate as Poison Control Calls "Explode" Across the U.S.

Kratom Safety Concerns Escalate as Poison Control Calls "Explode" Across the U.S.

FOR IMMEDIATE RELEASE

March 31, 2026 – A recent report from ScienceDaily highlights a dramatic and alarming surge in kratom-related poison center calls across the United States, with cases jumping over 1,200% in the last decade (2015-2025). This significant increase, alongside a sharp rise in hospitalizations and deaths, is raising serious concerns among health experts and underscores the urgent need for greater regulatory oversight within the kratom industry.

The University of Virginia Health analysis, cited by ScienceDaily, reveals that poison centers recorded a peak of 3,434 kratom cases in 2025, a stark contrast to just 258 in 2015. Hospitalizations involving kratom alone rose more than 1,150% in the same period, while cases where kratom was combined with other substances saw an almost 1,300% increase. Researchers attribute this concerning trend to the wider availability of kratom and the growing strength of newer, often unregulated products, particularly those with higher concentrations of alkaloids like 7-hydroxymitragynine.

Why This Matters to Kratom Merchants and Consumers

For consumers, these findings are a stark warning about the potential risks associated with unregulated kratom products. The lack of standardized labeling and quality control means consumers often cannot be sure of a product's true contents, potency, or purity, leading to unpredictable and potentially severe health outcomes, especially when mixed with other drugs or alcohol.

For kratom merchants, this escalating public health concern signals a critical juncture for the industry. Increased scrutiny from medical professionals and the media will likely intensify calls for stricter regulations, potentially leading to more state-level bans or the widespread adoption of comprehensive consumer protection laws. The industry's reputation and its continued legal operation hinge on proactive measures to ensure product safety and transparency.

Compliance Implications and Regulatory Landscape

The U.S. Food and Drug Administration (FDA) has consistently warned against kratom use, stating it is not lawfully marketed as a drug, dietary supplement, or food additive due to inadequate safety information and the risk of serious adverse events, including liver toxicity, seizures, and substance use disorder. This federal stance, coupled with the recent data, puts immense pressure on state legislatures to act.

In the absence of federal regulation, states have increasingly taken the lead in establishing their own frameworks, most notably through the Kratom Consumer Protection Act (KCPA). States like Oregon, Utah, and West Virginia have already implemented KCPA-style legislation, requiring businesses to obtain licenses and adhere to stringent testing and labeling standards. The "exploding cases" highlighted by ScienceDaily will undoubtedly fuel efforts to enact similar legislation in additional states, aiming to curb the sale of adulterated or mislabeled products.

What High-Risk Merchants Need to Know: COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, proactive compliance is no longer optional; it is essential for long-term viability and consumer trust.

1. Certificates of Analysis (COAs) and Lab Testing: It is paramount to obtain third-party COAs for every batch of kratom sold. These reports must verify product purity, ensuring the absence of contaminants such as heavy metals (e.g., lead), pesticides, and harmful pathogens like Salmonella, which have been linked to illnesses and deaths. Lab testing must also accurately quantify alkaloid content, particularly mitragynine and 7-hydroxymitragynine, to ensure products are not dangerously potent or inconsistent.
2. Accurate Labeling and Packaging: All products must feature clear, accurate labels detailing ingredients, alkaloid concentrations, recommended serving sizes, manufacturer information, and appropriate warnings. Misleading claims or packaging that appeals to minors must be avoided.
3. Adherence to State Laws: Merchants must be intimately familiar with and strictly adhere to all state and local regulations governing kratom sales, including age restrictions, which typically require consumers to be 18 or 21 years old.
4. Avoiding Adulteration: Selling products that contain undisclosed or added ingredients is a severe breach of trust and potentially illegal. Merchants must ensure their supply chain is robust and their products are pure.
5. Voluntary Industry Standards: Even in states without mandatory KCPA, voluntarily adhering to guidelines set by organizations like the American Kratom Association (AKA) demonstrates a commitment to responsible business practices and consumer safety.

The recent surge in adverse events serves as a critical reminder that the kratom industry must prioritize consumer safety through rigorous testing, transparent labeling, and strict adherence to evolving compliance standards. Failure to do so risks not only individual business operations but the future of the entire industry.